DRKS00023623已完成不适用
Posttraumatc headache - pain related evoked potentials and conditioned pain modulation as possible biomarkers for the identification of risk patients - PTH-PREP
eurologische KlinikBG Universitätsklinikum Bergmannsheil gGmbH0 个研究点目标入组 46 人开始时间: 2020年11月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •Inclusion criteria for patients:
- •- Acute or persistent headache resulting from a traumatic head injury
- •- The headache developed within 7 days of any of the following: the head injury, regaining consciousness after the head injury, discontinuation of medication that interferes with the ability to feel or report a headache after the head injury
- •- The headache is not better explained by another ICHD-3 diagnosis
- •Inclusion criteria for healthy control subjects:
- •- none of the exclusion criteria is met
- •- Present declaration of consent
- •- No abnormal result in the questionnaire or physical examination
- •- no use of drugs with peripheral or central nervous effects /side effect
- •- no neurological or psychiatric illness
排除标准
- •Exclusion criteria for patients:
- •- Age <18 years
- •- no declaration of consent
- •- Average pain intensity in the last 4 weeks <2 (NRS 0-10)
- •- Current pain intensity <2 (NRS 0-10)
- •- Insufficient knowledge of German or other communication problems
- •- Neuropathic pain syndromes
- •- Headache illness known before the accident
- •- Treatment with topical local anesthetics for <7 days in the last 6 weeks or for >7 days in the last 4 months
- •- Treatment with topical capsaicin in the past 6 months
- •- Epilepsy treated with anticonvulsants
- •- Psychiatric illness treated with anticonvulsants or antidepressants with a proven effect on neuropathic pain
- •- Other pain localization with a pain intensity =6 (NRS 0-10) on =15 days / month
- •- Other severe systemic or focal CNS affection
- •- Other central or peripheral neurological disorders
- •- peripheral arterial occlusive disease (except for stage Fontaine I)
- •- Serious cognitive or psychiatric impairment
- •Exclusion criteria for healthy control subjects:
- •- Age <18 years
- •- no declaration of consent
- •- Average pain intensity in the last 4 weeks> 2 (NRS 0-10)
- •- Current pain intensity >0 (NRS 0-10)
- •- Insufficient knowledge of German or other communication problems
- •- Neuropathies, radiculopathies, or nerve lesions
- •- Chronic pain syndromes
- •- Treatment with topical local anesthetics for the past 6 weeks
- •- Treatment with topical capsaicin in the past 6 months
- •- Epilepsy treated with anticonvulsants
- •- Psychiatric illness treated with anticonvulsants or antidepressants with a proven effect on neuropathic pain
- •- Other severe systemic or focal CNS affection
- •- Other central or peripheral neurological disorders
- •- peripheral arterial occlusive disease (except for stage Fontaine I)
- •- Serious cognitive or psychiatric impairment
研究者
相似试验
终止
3 期
A Prospective Controlled Treatment Trial for Post-Traumatic HeadachesPost-Traumatic HeadachesNCT03007420Boston Children's Hospital16
招募中
Unknown
Pain-Related Evoked Potentials to Nociceptive Stimuli by Application of TRP Channel AgentsJPRN-UMIN000049287iigata University of Health and Welfare25
已完成
不适用
Frequency of post spinal headache and some of related factorspost spinal headache.Other specified headache syndromesIRCT201203113305N3Vice-chancellor Of Research Babol University Of Medical Science300
尚未招募
Unknown
The Effect of Intraoperative Hemodynamic Changes on the Development of Postspinal Headache in Patients undergoing Cesarean Section with Spinal AnesthesiaPostspinal HeadacheIntraoperative Hemodynamic ChangesAnaesthesiology - Other anaesthesiologyReproductive Health and Childbirth - Childbirth and postnatal careAnaesthesiology - Pain managementACTRN12624000523505Serra Topal-Bursa City Hospital400
尚未招募
不适用
Evaluation of pain in severe head injury patients admitted to Neurointensive CareCTRI/2022/02/040072ational Institute of Mental Health and Neurosciences
